ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PAHC Phibro Animal S

5.225
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Phibro Animal S LSE:PAHC London Ordinary Share COM SHS USD0.0001 (REGS)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 5.225 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Phibro Animal Health Interim Results for the 6 -2-

11/02/2010 7:00am

UK Regulatory



range of animal health and nutrition products to the poultry, swine, cattle and 
aquaculture markets. PAHC is also a manufacturer and marketer of performance 
products for the ethanol and personal care industries. For more information, 
please visit www.pahc.com. 
 
For further information please contact: 
 
+----------------------------------------+----------------------+ 
| Phibro Animal Health Corporation       | +1 201 329 7300      | 
| Richard Johnson, Chief Financial       |                      | 
| Officer                                |                      | 
| investor.relations@pahc.com            |                      | 
+----------------------------------------+----------------------+ 
|                                        |                      | 
+----------------------------------------+----------------------+ 
| Panmure Gordon (UK) Limited            | +44 (0) 207 459 3600 | 
| Andrew Godber                          |                      | 
| Rakesh Sharma                          |                      | 
|                                        |                      | 
+----------------------------------------+----------------------+ 
Regulation S 
The securities discussed in this release have not been registered under the U.S. 
Securities Act of 1933, as amended ("Securities Act"), and may not be offered or 
sold in the United States or to U.S. Persons (as defined in Regulation S 
promulgated under the Securities Act) absent registration or an applicable 
exemption from the registration requirements of the Securities Act. 
 
Forward-Looking Statements 
This announcement contains forward-looking statements, including statements 
regarding management's expectations and beliefs regarding the future results or 
performance of the Company.  Because these statements apply to future events, 
they are subject to risks and uncertainties.  When used in this announcement, 
the words "anticipate," "believe," "estimate," "expect," "expectation," 
"project," , "intend" and similar expressions are intended to identify such 
forward-looking statements.  Our actual results could differ materially from 
those projected in the forward-looking statements.  Additionally, you should not 
consider past results to be an indication of our future performance.  We do not 
intend to update any of the forward-looking statements after the date of this 
announcement to conform these statements to actual results, to changes in 
management's expectations or otherwise, except as may be required by law. 
 
Financial Information 
The Company's Consolidated statements of operations, Consolidated balance 
sheets, Consolidated statements of cash flows and Reconciliation of net income 
(loss) to adjusted ebitda are as follows: 
 
 
+--------+--------+--------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| Consolidated statements of operations                                   |        |                  |        |                  |        | 
+-------------------------------------------------------------------------+--------+------------------+--------+------------------+--------+ 
|        |        |        |                  |        |                  |        |                  |        |                  |        | 
+--------+--------+--------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
|        |        |        |                Three months                  |        |                  Six months                  |        | 
+--------+--------+--------+----------------------------------------------+--------+----------------------------------------------+--------+ 
| For the periods ended    |       2009       |        |       2008       |        |       2009       |        |       2008       |        | 
| December 31              |                  |        |                  |        |                  |        |                  |        | 
+--------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
|        |        |        |                                             (unaudited)                                              |        | 
+--------+--------+--------+------------------------------------------------------------------------------------------------------+--------+ 
|        |        |        |                              (in thousands, except per share amounts)                                |        | 
+--------+--------+--------+------------------------------------------------------------------------------------------------------+--------+ 
|        |        |        |                  |        |                  |        |                  |        |                  |        | 
+--------+--------+--------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| Net sales                | $                |        | $                |        |                $ |        |                $ |        | 
|                          | 151,849          |        | 127,749          |        |          288,099 |        |          263,996 |        | 
+--------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| Cost of goods sold       |      111,327     |        |        97,441    |        |         211,488  |        |         203,048  |        | 
+--------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
|        | Gross profit    |        40,522    |        |        30,308    |        |          76,611  |        |          60,948  |        | 
+--------+-----------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| Selling, general and     |        25,754    |        |        20,531    |        |          49,869  |        |          40,993  |        | 
| administrative expenses  |                  |        |                  |        |                  |        |                  |        | 
+--------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
|        | Operating       |        14,768    |        |         9,777    |        |          26,742  |        |          19,955  |        | 
|        | income (loss)   |                  |        |                  |        |                  |        |                  |        | 
+--------+-----------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| Interest expense         |         8,772    |        |         7,376    |        |          17,371  |        |          14,633  |        | 
+--------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| Interest (income)        |            (18)  |        |            (15)  |        |             (38) |        |             (43) |        | 
+--------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| Foreign currency (gains) |        (1,128)   |        |         9,810    |        |          (6,280) |        |          19,826  |        | 
| losses, net              |                  |        |                  |        |                  |        |                  |        | 
+--------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| Other (income) expense,  |              54  |        |              26  |        |              87  |        |              62  |        | 
| net                      |                  |        |                  |        |                  |        |                  |        | 
+--------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
|        | Income (loss)   |         7,088    |        |        (7,420)   |        |          15,602  |        |         (14,523) |        | 
|        | before income   |                  |        |                  |        |                  |        |                  |        | 
|        | taxes           |                  |        |                  |        |                  |        |                  |        | 
+--------+-----------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| Provision (benefit) for  |         1,929    |        |            284   |        |           2,711  |        |           1,291  |        | 
| income taxes             |                  |        |                  |        |                  |        |                  |        | 
+--------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
|        | Income (loss)   | $                |        | $                |        |                $ |        |                $ |        | 
|        | from continuing | 5,159            |        | (7,704)          |        |           12,891 |        |         (15,814) |        | 
|        | operations      |                  |        |                  |        |                  |        |                  |        | 
+--------+-----------------+------------------+--------+------------------+--------+------------------+--------+------------------+--------+ 
| (Loss) from discontinued |                  |        |                  |        |                  |        |                  |        | 
| operations,              |                  |        |                  |        |                  |        |                  |        | 

1 Year Phibro Animal S Chart

1 Year Phibro Animal S Chart

1 Month Phibro Animal S Chart

1 Month Phibro Animal S Chart

Your Recent History

Delayed Upgrade Clock